BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11589676)

  • 21. Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.
    Wu FC; Balasubramanian R; Mulders TM; Coelingh-Bennink HJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):112-22. PubMed ID: 9920070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
    Jaakkola T; Ding YQ; Kellokumpu-Lehtinen P; Valavaara R; Martikainen H; Tapanainen J; Rönnberg L; Huhtaniemi I
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1496-505. PubMed ID: 2140831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal ranges for immunochemiluminometric gonadotropin assays.
    Neely EK; Hintz RL; Wilson DM; Lee PA; Gautier T; Argente J; Stene M
    J Pediatr; 1995 Jul; 127(1):40-6. PubMed ID: 7608809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproductive hormones of ICSI-conceived young adult men: the first results.
    Belva F; Roelants M; De Schepper J; Van Steirteghem A; Tournaye H; Bonduelle M
    Hum Reprod; 2017 Feb; 32(2):439-446. PubMed ID: 28007789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
    Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
    Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relative roles of follicle-stimulating hormone and luteinizing hormone in maintaining spermatogonial maturation and spermiation in normal men.
    Matthiesson KL; McLachlan RI; O'Donnell L; Frydenberg M; Robertson DM; Stanton PG; Meachem SJ
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3962-9. PubMed ID: 16895950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum luteinizing hormone concentrations increase 100-fold in females from 7 years to adulthood, as measured by time-resolved immunofluorometric assay.
    Apter D; Cacciatore B; Alfthan H; Stenman UH
    J Clin Endocrinol Metab; 1989 Jan; 68(1):53-7. PubMed ID: 2491866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of feeding an Asian or Western diet on sperm numbers, sperm quality and serum hormone levels in cynomolgus monkeys (Macaca fascicularis) injected with testosterone enanthate (TE) plus depot medroxyprogesterone acetate (DMPA).
    Suhana N; Sutyarso ; Moeloek N; Soeradi O; Sri Sukmaniah S; Supriatna J
    Int J Androl; 1999 Apr; 22(2):102-12. PubMed ID: 10194642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of sperm production by human luteinizing hormone in gonadotropin-suppressed normal men.
    Matsumoto AM; Paulsen CA; Bremner WJ
    J Clin Endocrinol Metab; 1984 Nov; 59(5):882-7. PubMed ID: 6434586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA; Yeung CH; Nieschlag E
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient reduction in serum HDL-cholesterol following medroxyprogesterone acetate and testosterone cypionate administration to healthy men.
    Friedl KE; Plymate SR; Paulsen CA
    Contraception; 1985 Apr; 31(4):409-20. PubMed ID: 3159547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testosterone undecanoate maintains spermatogenic suppression induced by cyproterone acetate plus testosterone undecanoate in normal men.
    Meriggiola MC; Costantino A; Cerpolini S; Bremner WJ; Huebler D; Morselli-Labate AM; Kirsch B; Bertaccini A; Pelusi C; Pelusi G
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5818-26. PubMed ID: 14671175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of circulating gonadotropin levels to GnRH agonist treatment in prostatic cancer.
    Huhtaniemi I; Venho P; Jacobi G; Rannikko S
    J Androl; 1991; 12(1):46-53. PubMed ID: 1901309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine, seminal and peripheral effects of depot medroxyprogesterone acetate and testosterone enanthate in men.
    Hedman M; Gottlieb C; Svanborg K; Bygdeman M; de la Torre B
    Int J Androl; 1988 Aug; 11(4):265-76. PubMed ID: 2971625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate.
    de Greef WJ; Dullaart J; Zeilmaker GH
    J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
    Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
    J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
    Salameh W; Bhasin S; Steiner B; McAdams LA; Peterson M; Swerdloff R
    Fertil Steril; 1991 Jan; 55(1):156-64. PubMed ID: 1898888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.